ImmuCell Corp (NASDAQ:ICCC)

4.57
Delayed Data
As of Dec 08
 +0.11 / +2.47%
Today’s Change
4.26
Today|||52-Week Range
7.84
-25.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues10.2M9.5M10.4M11.0M
 
 
 
 
 
Cost of Goods Sold3.5M3.3M4.3M4.3M
 
 
 
 
 
Depreciation And Amortization525.9K802.4K904.4K1.5M
 
 
 
 
 
 
Operating ExpensesGross Income6.3M5.4M5.2M5.2M
 
 
 
 
 
General Expenses4.1M4.5M5.5M7.3M
 
 
 
 
 
Research And Development1.2M1.2M2.0M3.5M
 
 
 
 
 
Total Operating Expenses8.1M8.7M10.7M13.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.1M890.2K-242.8K-2.1M
 
 
 
 
 
Interest Expense On Debt83.6K161.7K218.6K427.8K
 
 
 
 
 
Other Expenses5.6K-24.9K6.0K700.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.1M758.3K-438.5K-1.9M
 
 
 
 
 
Income Taxes-850.3K-249.9K-270.3K-461.6K
 
 
 
 
 
Net Income1.2M508.4K-168.1K-2.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M4.2M4.9M5.5M
 
 
 
 
 
Shares To Calculate EPS Diluted3.2M4.3M4.9M5.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.38$0.12-$0.03-$0.42
 
 
 
 
 
EPS Diluted$0.38$0.12-$0.03-$0.42